AZN

Astrazeneca News

Best deals to access real time data!
Real-time Level 1 for London Stock Exchange
Monthly Subscription
for only
$29.56
London Stock Exchange Level 2
Monthly Subscription
for only
$77.61
Real-time London Stock Exchange & FTSE
Monthly Subscription
for only
$88.69
VAT not included
Company Name Stock Ticker Symbol Market Type
Astrazeneca Plc AZN London Ordinary Share
  Price Change Change Percent Stock Price Last Traded
61.00 0.74% 8,284.00 11:35:20
Open Price Low Price High Price Close Price Prev Close
8,300.00 8,229.00 8,364.00 8,284.00 8,223.00
more quote information »
Industry Sector
PHARMACEUTICALS & BIOTECHNOLOGY

Recent News

Date Time Source Heading
12/08/202111:11IHNWFeaturedCybin Confirms Scientific Advice Meeting with UK Medical and Healthcare Products Regulatory Agency for Lead Candidate CYB003 for the Treatment of Major Depressive Disorder and Alcohol Use Disorder
12/08/20219:37IHNWFeaturedHealixa Appoints Rep. Denver Riggleman to the Board of Directors
12/08/20218:34IHNWFeaturedMax Resource Identifies 5 Drill Target Zones and Reports New Assay Results from DT-3 at URU, CESAR Project, NE Colombia
12/08/20218:00IHNWFeaturedInnerScope Hearing Technologies (OTC: INND) Receives Walmart Purchase Orders of $277,000+ for In-Store Product Sales
12/08/202119:37BWEVUSHELD (formerly AZD7442) long-acting antibody combination..
12/08/202117:08ALNCTOP NEWS: Astra's Covid-19 antibody drug Evusheld gets..
12/07/202105:03ALNCAstraZeneca enters development agreement with Ionis..
12/07/202103:09DJNAstraZeneca to Work with Ionis on Eplontersen Drug
12/07/202102:00UKREGAstraZeneca PLC AstraZeneca, Ionis to collaborate on..
12/01/202109:59UKREGAstraZeneca PLC Block listing Interim Review
11/30/202107:00DJNAstraZeneca: Lynparza Gets FDA Priority Review -- Update
11/30/202104:52ALNCAstraZeneca cancer drug Lynparza is granted priority review..
11/30/202102:49DJNAstraZeneca's Lynparza Supplemental New Drug Application..
11/30/202102:00UKREGAstraZeneca PLC Lynparza granted FDA Priority Review for..
11/29/202122:00GLOBEGenetron Health Announces Co-Development Agreement with..
11/24/202106:35ALNCHutchmed China shares rise on Orphathys and Tagrisso Phase 3..
11/23/202119:00GLOBEHUTCHMED and AstraZeneca Initiate SACHI Phase III Trial of..
11/19/202109:54PRNUSDeutsche Bank's Depositary Receipts Virtual Investor..
11/18/202105:37ALNCREPEAT: AstraZeneca gets positive results from two trials..
11/18/202104:56ALNCAstraZeneca ges positive results from two AZD7442 trials for..
11/18/202103:15DJNAstraZeneca Says Trials on Covid-19 Treatment Confirm..
11/17/202110:57DJNAstraZeneca's Lokelma Gets FDA Fast-Track Designation in..
11/16/202102:52DJNAstraZeneca Has Delivered 2 Billion Covid-19 Vaccine Doses..
11/15/202111:00UKREGAstraZeneca PLC Director/PDMR Shareholding
11/15/202109:09ALNCAstraZeneca, Moderna post promising findings from heart drug
11/12/202105:07DJNCorrection to AstraZeneca Earnings Article
11/12/202103:51ALNCTOP NEWS: AstraZeneca profit takes hit but revenue gets..
11/12/202103:11DJNAstraZeneca Swung to 3Q Loss Despite Higher Revenue;..
11/12/202102:00UKREGAstraZeneca PLC AZN: Year to date and Q3 2021 results
11/11/202108:35PRNUSInternational companies to host live webcasts at Deutsche..
11/01/202111:00UKREGAstraZeneca PLC Total Voting Rights
11/01/202105:14ALNCTOP NEWS: Astra transfers drug rights to Covis in USD270..
11/01/202103:47DJNAstraZeneca to Transfer Eklira, Duaklir Global Rights to..
11/01/202103:10ALNC*Hutchmed and AstraZeneca begin study of renal cell..
11/01/202103:00UKREGAstraZeneca PLC AstraZeneca to transfer rights to Eklira,..
10/25/202103:16ALNCAstraZeneca cancer drug trial shows improved overall..
10/25/202102:46DJNAstraZeneca's Imfinzi-Chemotherapy Combination Improved..
10/25/202102:00UKREGAstraZeneca PLC Imfinzi improved survival in biliary tract..
10/18/202104:08ALNCTOP NEWS: AstraZeneca urges shareholders to veto TRC..
10/18/202102:50DJNAstraZeneca Recommends Shareholders Reject TRC Capital..
10/18/202102:00UKREGAstraZeneca PLC AZ recommends ADS holders reject mini-tender..
10/15/202108:05DJNAstraZeneca Says Study in Liver Cancer Meets Objective
10/15/202103:34ALNCAstraZeneca says Imfinzi combination drug boosts liver..
10/15/202102:49DJNAstraZeneca Says Combination of Tremelimumab and Imfinzi..
10/15/202102:00UKREGAstraZeneca PLC Imfinzi & tremelimumab improved OS in liver..
10/14/202110:03ALNCEuropean drug watchdog reviews AstraZeneca anti-Covid..
10/11/202111:00ALNCIN THE KNOW: AstraZeneca's investment strategy paying off -..
10/11/202103:39ALNCTOP NEWS: AstraZeneca gets positive results from Covid-19..
10/11/202102:44DJNAstraZeneca's AZD7442 Trial Showed Reduced Risk of..
10/11/202102:00UKREGAstraZeneca PLC AZD7442 PhIII trial positive in COVID..
10/08/202107:53DJNAstraZeneca's Tezepelumab Gets Orphan Drug Designation in..
10/08/202107:52DJNAstraZeneca: Tezepelumab Gets FDA Orphan Designation for..
10/05/202105:03ALNCAstraZeneca seeks emergency FDA approval for drug preventing..
10/05/202102:43DJNAstraZeneca Requests US FDA Emergency Use Authorization for..
See more news about this stock »


Your Recent History
LSE
AZN
Astrazenec..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.